DEA: Catalent Seeks Permit to Import Controlled Substances for Clinical Trials
August 22, 2025
August 22, 2025
WASHINGTON, Aug. 22 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration is reviewing an application from Catalent CTS LLC, Kansas City, Missouri, to become a registered importer of controlled substances for clinical trials.
The company seeks to import a group of substances, including Gamma Hydroxybutyric Acid, Marihuana, Marihuana Extract, and Tetrahydrocannabinols. The company's intent is to use these substances as bulk and dosage unit products to support . . .
The company seeks to import a group of substances, including Gamma Hydroxybutyric Acid, Marihuana, Marihuana Extract, and Tetrahydrocannabinols. The company's intent is to use these substances as bulk and dosage unit products to support . . .